retatrutide heart issues What is known about the cardiovascular safety of in adults with obesity and type 2 diabetes, and how should it be used in patients with existing cardiovascular disease? Does Retatrutide Lower Blood Pressure?

14.5 Glycemic Control Trial in Pediatric Patients 10 Years of Age and Older with Type 2 Diabetes Mellitus The efficacy and safety of BYDUREON 2 mg given subcutaneously once weekly or placebo was evaluated in a 24 week randomized, double blind, placebo controlled, parallel group study (Trial 8 - NCT01554618) in 82 patients aged 10 to 17 years with type 2 diabetes treated with diet and exercise alone or in combination with a stable dose of oral antidiabetic agents and/or insulin

Wegovy and Zepbound are higher-dose versions cleared exclusively for chronic weight management, while Victoza and Byetta have shorter daily dosing windows

Lusk notes the study found a "fairly large decline" in the amount of soda and sugary drinks purchased and consumed

The intra-assay and interassay variations were 11.7% and 10.2%, with mean concentrations of 11.6 and 23.2 pg/mL [1]